Search Results 331-340 of 13944 for Moderate acute malnutrition

1. LY4268989 (MORF-057) Co-Administered With Mirikizumab In Adults With Moderately To Severely Active Ulcerative Colitis: - Mayo Clinic

   LY4268989 (MORF-057) Co-Administered With Mirikizumab In Adults With Moderately To Severely Active Ulcerative Colitis: · Share · Facebook · Twitter.

2. A Study To Assess Whether Etrolizumab Is A Safe And Effective Treatment For Participants With Moderately To Severely Active Crohn's Disease (CD) - Mayo Clinic

   History of moderate or severe allergic or anaphylactic/anaphylactoid reactions to chimeric, human, or humanized antibodies, fusion proteins, or murine ...

3. COMPASSION S3 - Evaluation Of The SAPIEN 3 Transcatheter Heart Valve In Patients With Pulmonary Valve Dysfunction - Mayo Clinic

   Subject presents with at least moderate PR and/or mean RVOT gradient ≥ 35 mmHg. 4. The subject/subject's legally authorized representative has been ...

4. Evaluate Acute Pain Management Experience during the Perioperative Period - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Enlarged breasts in men (gynecomastia) - Symptoms and causes - Mayo Clinic

   Malnutrition and starvation. When the body doesn't get enough nutrition, testosterone levels drop. But estrogen levels stay the same. This causes an ...

6. A Study to Support Increased Information and Participation in the Decision Making Process for Parents of Children who have Acute Inflammation of the Middle Ear - Mayo Clinic

   A Study to Support Increased Information and Participation in the Decision Making Process for Parents of Children who have Acute Inflammation of the Middle Ear.

7. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

   A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma · Share ...

8. A Study To Assess The Effectiveness And Safety Of Ublituximab In Combination With Umbralisib And Venetoclax (U2-V) Compared To Ublituximab And Umbralisib (U2) In Subjects With Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   Any severe and/or uncontrolled medical conditions or other conditions ... Requirement for use of strong or moderate CYP3A inhibitors, strong or moderate ...

9. Small intestinal bacterial overgrowth (SIBO) - Symptoms and causes - Mayo Clinic

   The excess bacteria often cause diarrhea and may cause weight loss and malnutrition. While SIBO is often a complication of stomach (abdominal) surgery, this ...

10. Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma - Mayo Clinic

    History of myocardial infarction (< 6 months), acute coronary syndromes ... Current corneal epithelial disease except for mild punctuate keratopathy.